Cutera Share Holder Equity 2010-2024 | CUTR
Cutera share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Cutera Annual Share Holder Equity (Millions of US $) |
2023 |
$-172 |
2022 |
$-15 |
2021 |
$57 |
2020 |
$57 |
2019 |
$46 |
2018 |
$46 |
2017 |
$65 |
2016 |
$61 |
2015 |
$50 |
2014 |
$81 |
2013 |
$84 |
2012 |
$91 |
2011 |
$92 |
2010 |
$95 |
2009 |
$101 |
Cutera Quarterly Share Holder Equity (Millions of US $) |
2024-09-30 |
$-253 |
2024-06-30 |
$-216 |
2024-03-31 |
$-193 |
2023-12-31 |
$-172 |
2023-09-30 |
$-116 |
2023-06-30 |
$-74 |
2023-03-31 |
$-42 |
2022-12-31 |
$-15 |
2022-09-30 |
$15 |
2022-06-30 |
$24 |
2022-03-31 |
$43 |
2021-12-31 |
$57 |
2021-09-30 |
$55 |
2021-06-30 |
$53 |
2021-03-31 |
$42 |
2020-12-31 |
$57 |
2020-09-30 |
$52 |
2020-06-30 |
$52 |
2020-03-31 |
$34 |
2019-12-31 |
$46 |
2019-09-30 |
$44 |
2019-06-30 |
$43 |
2019-03-31 |
$39 |
2018-12-31 |
$46 |
2018-09-30 |
$70 |
2018-06-30 |
$69 |
2018-03-31 |
$68 |
2017-12-31 |
$65 |
2017-09-30 |
$61 |
2017-06-30 |
$60 |
2017-03-31 |
$59 |
2016-12-31 |
$61 |
2016-09-30 |
$52 |
2016-06-30 |
$48 |
2016-03-31 |
$50 |
2015-12-31 |
$50 |
2015-09-30 |
$49 |
2015-06-30 |
$68 |
2015-03-31 |
$79 |
2014-12-31 |
$81 |
2014-09-30 |
$81 |
2014-06-30 |
$82 |
2014-03-31 |
$83 |
2013-12-31 |
$84 |
2013-09-30 |
$86 |
2013-06-30 |
$93 |
2013-03-31 |
$93 |
2012-12-31 |
$91 |
2012-09-30 |
$88 |
2012-06-30 |
$88 |
2012-03-31 |
$88 |
2011-12-31 |
$92 |
2011-09-30 |
$91 |
2011-06-30 |
$93 |
2011-03-31 |
$93 |
2010-12-31 |
$95 |
2010-09-30 |
$96 |
2010-06-30 |
$98 |
2010-03-31 |
$100 |
2009-12-31 |
$101 |
2009-09-30 |
$100 |
2009-06-30 |
$112 |
2009-03-31 |
$111 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Laser Systems and Components |
$0.007B |
$0.212B |
Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system.
|